Compare SPWH & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPWH | ELOX |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 43.8M |
| IPO Year | 2014 | N/A |
| Metric | SPWH | ELOX |
|---|---|---|
| Price | $1.24 | $12.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.94 | N/A |
| AVG Volume (30 Days) | ★ 537.7K | 12.5K |
| Earning Date | 06-02-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,209,182,000.00 | N/A |
| Revenue This Year | $2.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $1.08 | $12.90 |
| 52 Week High | $3.87 | $14.28 |
| Indicator | SPWH | ELOX |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | N/A |
| Support Level | $1.23 | N/A |
| Resistance Level | $1.50 | N/A |
| Average True Range (ATR) | 0.10 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 10.64 | 0.00 |
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others. The company also offers an e-commerce experience, extensive in-store events and educational programming.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.